Holen Sie sich die Stockscreener-App
2.62
1.55%
0.04
Adlai Nortye Ltd Adr Aktie (ANL) Neueste Nachrichten
Adlai Nortye shares hold Buy rating by H.C. Wainwright on oncology programs - Investing.com
Adlai Nortye stock strengthened by oncology trial results, H.C. Wainwright keeps at Buy list - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline - Investing.com
ANL stock touches 52-week low at $1.85 amid sharp annual decline By Investing.com - Investing.com South Africa
Adlai Nortye stock plunges to 52-week low of $1.89 - Investing.com
Adlai Nortye stock plunges to 52-week low of $1.89 By Investing.com - Investing.com Canada
Adlai Nortye Ltd. Sponsored ADR (ANL) Loses -33.06% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance
H.C. Wainwright sees upside in Adlai Nortye stock amid robust oncology pipeline - Investing.com
Adlai Nortye Reports Strong 2024 Mid-Year Results - TipRanks
Adlai Nortye releases unaudited H1 2024 results, adds new director - Investing.com
Adlai Nortye Announces Executive Leadership Transition - TipRanks
Closing Bell Recap: Adlai Nortye Ltd. ADR (ANL) Ends at 7.70, Reflecting a -6.78 Downturn – DWinneX - The Dwinnex
Adlai Nortye to Unveil Cancer Drug Data at ASCO 2024TipRanks.com - TipRanks
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024 - GlobeNewswire Inc.
Are Medical Stocks Lagging Adlai Nortye Ltd. Sponsored ADR (ANL) This Year? - Yahoo Finance Australia
Why Take-Two Interactive Software Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Friday's Mid-Day Session - Markets Insider
symbol__ Stock Quote Price and Forecast - CNN
Adlai Nortye (ANL) Stock Price, News & Analysis - MarketBeat
IPO Update: Adlai Nortye Readies $72 Million U.S. IPO (Pending:ANL) - Seeking Alpha
1.80%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):